Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1993 Sep;36(3):195–200. doi: 10.1111/j.1365-2125.1993.tb04216.x

Individual and combined effects of cimetidine and ciprofloxacin on theophylline metabolism in male nonsmokers.

C M Loi 1, B M Parker 1, B J Cusack 1, R Vestal 1
PMCID: PMC1364637  PMID: 9114903

Abstract

1. The individual and combined effects of cimetidine and ciprofloxacin on theophylline metabolism were examined in six young male nonsmokers. 2. Treatment sequence consisted of 7 days each of cimetidine 400 mg p.o. every 12 h. ciprofloxacin 500 mg p.o. every 12 h, and the combination of cimetidine and ciprofloxacin. 3. Studies of theophylline pharmacokinetics were performed at baseline and on the fifth day of each regimen. 4. Individually, cimetidine and ciprofloxacin decreased the clearance of theophylline by 25% and 32%, respectively. Therapy with the combined regimen resulted in a 41% reduction in theophylline clearance, which was greater than that achieved with each drug alone (P < 0.01). 5. Ciprofloxacin, in contrast to cimetidine, inhibited N-demethylations of theophylline to a significantly greater extent than the hydroxylation pathway. Combined treatment produced a further decline in formation of 1,3-dimethyluric acid than each drug alone. 6. These data suggest that coadministration of cimetidine and ciprofloxacin exerts a greater impairment of theophylline biotransformation than each inhibitor alone. The enhanced inhibitory effect from the two inhibitors will occur only when sub-maximal doses of each individual agent are used.

Full text

PDF
198

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birkett D. J., Miners J. O., Attwood J. Secondary metabolism of theophylline biotransformation products in man--route of formation of 1-methyluric acid. Br J Clin Pharmacol. 1983 Jan;15(1):117–119. doi: 10.1111/j.1365-2125.1983.tb01475.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cusack B. J., Dawson G. W., Mercer G. D., Vestal R. E. Cigarette smoking and theophylline metabolism: effects of cimetidine. Clin Pharmacol Ther. 1985 Mar;37(3):330–336. doi: 10.1038/clpt.1985.48. [DOI] [PubMed] [Google Scholar]
  3. Davis R. L., Quenzer R. W., Kelly H. W., Powell J. R. Effect of the addition of ciprofloxacin on theophylline pharmacokinetics in subjects inhibited by cimetidine. Ann Pharmacother. 1992 Jan;26(1):11–13. doi: 10.1177/106002809202600102. [DOI] [PubMed] [Google Scholar]
  4. Feely J., Pereira L., Guy E., Hockings N. Factors affecting the response to inhibition of drug metabolism by cimetidine--dose response and sensitivity of elderly and induced subjects. Br J Clin Pharmacol. 1984 Jan;17(1):77–81. doi: 10.1111/j.1365-2125.1984.tb05002.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Grygiel J. J., Birkett D. J. Effect of age on patterns of theophylline metabolism. Clin Pharmacol Ther. 1980 Oct;28(4):456–462. doi: 10.1038/clpt.1980.188. [DOI] [PubMed] [Google Scholar]
  6. Lelo A., Birkett D. J., Robson R. A., Miners J. O. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol. 1986 Aug;22(2):177–182. doi: 10.1111/j.1365-2125.1986.tb05246.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Muir K. T., Jonkman J. H., Tang D. S., Kunitani M., Riegelman S. Simultaneous determinations by theophylline and its major metabolites in urine by reversed-phase ion-pair high-performance liquid chromatography. J Chromatogr. 1980 Nov 14;221(1):85–95. doi: 10.1016/s0378-4347(00)81010-5. [DOI] [PubMed] [Google Scholar]
  8. Nix D. E., DeVito J. M., Whitbread M. A., Schentag J. J. Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green. J Antimicrob Chemother. 1987 Feb;19(2):263–269. doi: 10.1093/jac/19.2.263. [DOI] [PubMed] [Google Scholar]
  9. Reitberg D. P., Bernhard H., Schentag J. J. Alteration of theophylline clearance and half-life by cimetidine in normal volunteers. Ann Intern Med. 1981 Nov;95(5):582–585. doi: 10.7326/0003-4819-95-5-582. [DOI] [PubMed] [Google Scholar]
  10. Robson R. A., Begg E. J., Atkinson H. C., Saunders D. A., Frampton C. M. Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline. Br J Clin Pharmacol. 1990 Apr;29(4):491–493. doi: 10.1111/j.1365-2125.1990.tb03669.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Robson R. A., Matthews A. P., Miners J. O., McManus M. E., Meyer U. A., Hall P. M., Birkett D. J. Characterisation of theophylline metabolism in human liver microsomes. Br J Clin Pharmacol. 1987 Sep;24(3):293–300. doi: 10.1111/j.1365-2125.1987.tb03172.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Robson R. A., Miners J. O., Matthews A. P., Stupans I., Meller D., McManus M. E., Birkett D. J. Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies. Biochem Pharmacol. 1988 May 1;37(9):1651–1659. doi: 10.1016/0006-2952(88)90423-6. [DOI] [PubMed] [Google Scholar]
  13. Sarkar M. A., Hunt C., Guzelian P. S., Karnes H. T. Characterization of human liver cytochromes P-450 involved in theophylline metabolism. Drug Metab Dispos. 1992 Jan-Feb;20(1):31–37. [PubMed] [Google Scholar]
  14. Sarkar M., Polk R. E., Guzelian P. S., Hunt C., Karnes H. T. In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes. Antimicrob Agents Chemother. 1990 Apr;34(4):594–599. doi: 10.1128/aac.34.4.594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schwartz J., Jauregui L., Lettieri J., Bachmann K. Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum. Antimicrob Agents Chemother. 1988 Jan;32(1):75–77. doi: 10.1128/aac.32.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vestal R. E., Cusack B. J., Mercer G. D., Dawson G. W., Park B. K. Aging and drug interactions. I. Effect of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men. J Pharmacol Exp Ther. 1987 May;241(2):488–500. [PubMed] [Google Scholar]
  17. Vestal R. E., Eiriksson C. E., Jr, Musser B., Ozaki L. K., Halter J. B. Effect of intravenous aminophylline on plasma levels of catecholamines and related cardiovascular and metabolic responses in man. Circulation. 1983 Jan;67(1):162–171. doi: 10.1161/01.cir.67.1.162. [DOI] [PubMed] [Google Scholar]
  18. Vestal R. E., Thummel K. E., Musser B., Mercer G. D. Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration. Br J Clin Pharmacol. 1983 Apr;15(4):411–418. doi: 10.1111/j.1365-2125.1983.tb01523.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wijnands W. J., Vree T. B., van Herwaarden C. L. The influence of quinolone derivatives on theophylline clearance. Br J Clin Pharmacol. 1986 Dec;22(6):677–683. doi: 10.1111/j.1365-2125.1986.tb02957.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES